Michael Ehlers, Ascidian Therapeutics CEO (Photo: Kevin Trimmer)

Ex­clu­sive: As­cid­i­an CEO Michael Ehlers leaves Ap­ple Tree Part­ners for MPM BioIm­pact

As­cid­i­an Ther­a­peu­tics CEO Michael Ehlers is leav­ing the ven­ture in­vestor that serves as his home base and will join MPM BioIm­pact as an en­tre­pre­neur-part­ner on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.